Rewiring Recovery: Cognitive and Motor Gains Through Personalized Neurofeedback After Tumor Resection

In the evolving landscape of neuro-oncological rehabilitation, this 2025 study published in Applied Psychophysiology and Biofeedback introduces a promising intervention that merges EEG neurofeedback (NF) with intensive motor therapy to enhance recovery after brain tumor resection. Brain and central nervous system (CNS) tumors, though increasingly treatable, often leave survivors with debilitating cognitive and motor deficits. Traditional rehabilitation approaches focus heavily on physical recovery, while cognitive and affective impairments—such as deficits in memory, attention, and executive function—can persist long after surgery.

Neurofeedback, a form of EEG-based biofeedback, enables individuals to train self-regulation of neural activity by providing real-time feedback on brainwave patterns. Through mechanisms of Hebbian and homeostatic neuroplasticity, neurofeedback can modulate maladaptive cortical activity and facilitate neural reorganization. Although its utility in stroke and traumatic brain injury is well-documented, its application in post-oncological neurorehabilitation remains largely unexplored.

This study, led by Gianvito Lagravinese and colleagues—a list I'm proud to be included in—aimed to assess whether personalized EEG-guided neurofeedback could serve as a feasible, safe, and effective adjunct to motor rehabilitation in patients recovering from brain tumor surgery.

Methods

Seven inpatients (5 women, 2 men; aged 46–76 years) with postoperative cognitive deficits following brain tumor resection were enrolled in a three-week, multimodal rehabilitation program. Each patient completed 15 sessions of EEG-based neurofeedback (35 minutes/session, five times weekly), combined with daily motor rehabilitation focused on mobilization, strength, and balance recovery.

Neurofeedback Protocols

EEG recordings used the 10–20 system via a 21-channel BE PLUS PRO system. Active sites—Cz, C3, C4, F3, or FCz—were individualized based on lesion location and qEEG abnormalities. Protocols targeted inhibition of theta (4–7.5 Hz) and high beta (22–26 Hz) while rewarding either low beta (13–18 Hz) or sensorimotor rhythm (SMR; 12–15 Hz). The choice of reward frequency depended on clinical presentation:

• Theta/Beta protocol: used for attentional or executive deficits, rewarding low beta.

• SMR/Theta protocol: used for sensorimotor dysfunction or arousal dysregulation, rewarding SMR.

Thresholds were manually adjusted to maintain ~70% reinforcement, ensuring patient engagement. This individualized design aimed to optimize cortical self-regulation and encourage adaptive neuroplasticity.

Assessments

Comprehensive pre- and post-intervention evaluations included:

• Quantitative EEG (qEEG): measuring absolute and relative power, and spectral ratios (Delta/Beta, Theta/Beta, Alpha/High Beta).

• Neuropsychological battery: assessing global cognition, attention, memory, executive functions, visuospatial processing, language, and mood (e.g., MMSE, RAVLT, Stroop, BDI-II, STAI).

• Motor outcomes: measured via Modified Barthel Index (MBI) and Functional Independence Measure (FIM).

Reliable Change Index (RCI) analyses determined whether changes exceeded expected test–retest variability.

Results

All participants completed the neurofeedback protocol without adverse events. qEEG analyses revealed heterogeneous but measurable modulations across all patients. Several showed normalization of previously abnormal Delta/Beta ratios, consistent with improved cortical activation and attentional regulation.

• Patient 1 exhibited broad normalization across all frequency bands (notably Delta: ΔZ = –4.69), and strong clinical gains in memory, language, mood, and motor performance.

• Patients 2–3 displayed significant reductions in Theta/Beta ratios, aligned with improved attention and executive function.

• Patients 5–7 benefited from SMR protocols, showing gains in motor and affective domains.

Reliable cognitive improvements were observed in all patients, particularly in verbal fluency, working memory, and visuospatial processing. Functional gains (FIM, BIM) were significant across the cohort, with several patients demonstrating clinically meaningful improvements in daily living independence.

A key correlation emerged: reductions in Delta/Beta ratios were significantly associated with improved delayed verbal recall (ρ = –0.83, p = 0.02)—suggesting a neurophysiological signature of memory recovery.

Discussion

This case series highlights the multidimensional potential of neurofeedback as an adjunct to neurorehabilitation in brain tumor survivors. The integration of qEEG-guided feedback with intensive motor therapy yielded consistent improvements in both cortical activity and behavioral outcomes. The findings align with prior evidence from stroke and TBI populations, underscoring neurofeedback’s capacity to enhance neuroplasticity and self-regulation through reinforcement-based modulation of neural oscillations.

From a clinical perspective, the ability to target specific neural dysregulations—such as elevated Delta/Beta ratios linked to hypoarousal or attentional deficits—represents a major step toward individualized rehabilitation. Moreover, coupling motor and cognitive retraining leverages cross-modal plasticity, enhancing recovery efficiency.

Limitations include the small sample size, absence of a control group, and unmonitored participant strategies during training. Nevertheless, the study demonstrates feasibility and provides a framework for integrating neurofeedback within standard neurorehabilitation programs.

Brendan’s Perspective

Neurofeedback in neuro-oncology rehabilitation embodies the next frontier of applied neuroscience—restoring self-regulation after structural brain injury. What stands out in this study is not merely the data, but the clinical pragmatism: individualized qEEG-informed protocols, delivered within real-world rehabilitation constraints, producing tangible outcomes.

In practice, these results advocate for EEG-informed personalization—using qEEG not just diagnostically, but prescriptively. For patients exhibiting excessive slow-wave activity (Delta/Theta) over central or frontal sites, theta/beta downtraining at Cz or Fz remains a logical starting point. Conversely, individuals with disrupted motor regulation benefit from SMR enhancement at Cz or C4, targeting 12–15 Hz to stabilize thalamocortical loops.

Future practice could integrate real-time qEEG adaptation—adjusting reward frequencies dynamically as cortical balance shifts. Additionally, combining neurofeedback with mindfulness-based strategies or heart rate variability (HRV) biofeedback may amplify cross-system regulation, particularly for affective resilience post-surgery.

Clinically, what we’re witnessing is a redefinition of neurorehabilitation—one that honors the brain’s capacity for reorganization even after invasive procedures. These findings invite practitioners to consider neurofeedback not as an experimental add-on, but as a core element of comprehensive recovery.

Conclusion

This exploratory case series demonstrates that integrating EEG neurofeedback with intensive motor rehabilitation is feasible, safe, and potentially transformative for patients recovering from brain tumor surgery. Improvements in attention, memory, and executive function were paralleled by normalization in EEG spectral patterns—highlighting the neuroplastic potential of the recovering brain.

While further randomized controlled trials are warranted, this study reinforces a growing truth in neuroscience: when guided with precision, the brain can indeed learn to heal itself.

Reference

Lagravinese, G., Nicolardi, V., Aresta, S., Guglielmo, M., Tagliente, S., Montenegro, F., Battista, P., Parsons, B., & De Trane, S. (2025). Rewiring recovery: Cognitive and motor gains through personalized neurofeedback after tumor resection—A case series from neurorehabilitation practice. Applied Psychophysiology and Biofeedback.https://doi.org/10.1007/s10484-025-09743-9